General Information

Ensuring access to medicines and public health supplies is one of the greatest challenges facing the Region of the Americas. Factors contributing to inequitable access to medicines include weak public health policy and economic or commercial barriers either at the national or global level.

The attainment of the global mandates presented through the United Nations Millennium Declaration, September 2000, and the identification of two priority public health targets (on the one hand HIV/AIDS, malaria, and other major diseases; and on the other the reduction of child mortality), will require access to essential public health supplies.

PAHO Strategic Lines of Action

In accordance with the resolution of the Directing Council, PAHO aims to focus on determinants of access and address key issues in the selection and supply of public health commodities in priority diseases within the Region, focusing on three strategic lines of action:
• In the development of national pharmaceutical policy, promoting coherent generic drug policy as a means to increase the availability and use of quality essential medicines.

• Developing cost containment strategies for Essential Public Health Supplies, with focus on two areas: pricing and intellectual property.

• Strengthening public health commodity supply systems to ensure continuity and availability.

Related Documents


Proyect of the UN - Development Goals of the Milenum



Special Working Group on Access to Medicines - Goals of the Milenium




Background Paper
of the
Task Force on Major Diseases and Access to Medicine,
Subgroup on Tuberculosis


Access to Medicines

LINK to the WHO web page